Olanzapine Teva

Negara: Uni Eropa

Bahasa: Inggris

Sumber: EMA (European Medicines Agency)

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
25-09-2023
Karakteristik produk Karakteristik produk (SPC)
25-09-2023

Bahan aktif:

olanzapine

Tersedia dari:

Teva B.V. 

Kode ATC:

N05AH03

INN (Nama Internasional):

olanzapine

Kelompok Terapi:

Psycholeptics

Area terapi:

Schizophrenia; Bipolar Disorder

Indikasi Terapi:

AdultsOlanzapine is indicated for the treatment of schizophrenia.Olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Olanzapine is indicated for the treatment of moderate to severe manic episode.In patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Ringkasan produk:

Revision: 30

Status otorisasi:

Authorised

Tanggal Otorisasi:

2007-12-12

Selebaran informasi

                                82
B. PACKAGE LEAFLET
83
PACKAGE LEAFLET: INFORMATION FOR THE USER
OLANZAPINE TEVA 2.5 MG FILM-COATED TABLETS
OLANZAPINE TEVA 5 MG FILM-COATED TABLETS
OLANZAPINE TEVA 7.5 MG FILM-COATED TABLETS
OLANZAPINE TEVA 10 MG FILM-COATED TABLETS
OLANZAPINE TEVA 15 MG FILM-COATED TABLETS
OLANZAPINE TEVA 20 MG FILM-COATED TABLETS
olanzapine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Olanzapine Teva is and what it is used for
2.
What you need to know before you take Olanzapine Teva
3.
How to take Olanzapine Teva
4.
Possible side effects
5.
How to store Olanzapine Teva
6.
Contents of the pack and other information
1.
WHAT OLANZAPINE TEVA IS AND WHAT IT IS USED FOR
Olanzapine Teva contains the active substance olanzapine. Olanzapine
Teva belongs to a group of
medicines called antipsychotics and is used to treat the following
conditions:
-
Schizophrenia, a disease with symptoms such as hearing, seeing or
sensing things which are not
there, mistaken beliefs, unusual suspiciousness, and becoming
withdrawn. People with this
disease may also feel depressed, anxious or tense.
-
Moderate to severe manic episodes, a condition with symptoms of
excitement or euphoria.
Olanzapine Teva has been shown to prevent recurrence of these symptoms
in patients with bipolar
disorder whose manic episode has responded to olanzapine treatment.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE OLANZAPINE TEVA
_ _
DO NOT TAKE OLANZAPINE TEVA
-
if you are allergic to olanzapine or any of the other ingredients of
this medicine (listed in sect
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Olanzapine Teva 2.5 mg film-coated tablets
Olanzapine Teva 5 mg film-coated tablets
Olanzapine Teva 7.5 mg film-coated tablets
Olanzapine Teva 10 mg film-coated tablets
Olanzapine Teva 15 mg film-coated tablets
Olanzapine Teva 20 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Olanzapine Teva 2.5 mg film-coated tablets
Each film-coated tablet contains 2.5 mg olanzapine.
_Excipient with known effect _
Each film-coated tablet contains 71.3 mg lactose.
Olanzapine Teva 5 mg film-coated tablets
Each film-coated tablet contains 5 mg olanzapine.
_Excipient with known effect _
Each film-coated tablet contains 68.9 mg lactose.
Olanzapine Teva 7.5 mg film-coated tablets
Each film-coated tablet contains 7.5 mg olanzapine.
_Excipient with known effect _
Each film-coated tablet contains 103.3 mg lactose.
Olanzapine Teva 10 mg film-coated tablets
Each film-coated tablet contains 10 mg olanzapine.
_Excipient with known effect _
Each film-coated tablet contains 137.8 mg lactose.
Olanzapine Teva 15 mg film-coated tablets
Each film-coated tablet contains 15 mg olanzapine.
_Excipient with known effect _
Each film-coated tablet contains 206.7 mg lactose.
Olanzapine Teva 20 mg film-coated tablets
Each film-coated tablet contains 20 mg olanzapine.
_Excipient with known effect _
Each film-coated tablet contains 275.5 mg lactose.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet
Olanzapine Teva 2.5 mg film-coated tablets
White, biconvex, round film-coated tablets, debossed ”OL 2.5” on
one side and plain on the other.
Olanzapine Teva 5 mg film-coated tablets
White, biconvex, round film-coated tablets, debossed ”OL 5” on one
side and plain on the other.
Olanzapine Teva 7.5 mg film-coated tablets
White, biconvex, round film-coated tablets, debossed ”OL 7.5” on
one side and plain on the other.
3
Olanzapine Teva 10 mg film-coated tablets
White, biconvex, round film-coated tablets, debossed 
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Bulgar 25-09-2023
Karakteristik produk Karakteristik produk Bulgar 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Bulgar 01-03-2013
Selebaran informasi Selebaran informasi Spanyol 25-09-2023
Karakteristik produk Karakteristik produk Spanyol 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Spanyol 01-03-2013
Selebaran informasi Selebaran informasi Cheska 25-09-2023
Karakteristik produk Karakteristik produk Cheska 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Cheska 01-03-2013
Selebaran informasi Selebaran informasi Dansk 25-09-2023
Karakteristik produk Karakteristik produk Dansk 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Dansk 01-03-2013
Selebaran informasi Selebaran informasi Jerman 25-09-2023
Karakteristik produk Karakteristik produk Jerman 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Jerman 01-03-2013
Selebaran informasi Selebaran informasi Esti 25-09-2023
Karakteristik produk Karakteristik produk Esti 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Esti 01-03-2013
Selebaran informasi Selebaran informasi Yunani 25-09-2023
Karakteristik produk Karakteristik produk Yunani 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Yunani 01-03-2013
Selebaran informasi Selebaran informasi Prancis 25-09-2023
Karakteristik produk Karakteristik produk Prancis 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Prancis 01-03-2013
Selebaran informasi Selebaran informasi Italia 25-09-2023
Karakteristik produk Karakteristik produk Italia 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Italia 01-03-2013
Selebaran informasi Selebaran informasi Latvi 25-09-2023
Karakteristik produk Karakteristik produk Latvi 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Latvi 01-03-2013
Selebaran informasi Selebaran informasi Lituavi 25-09-2023
Karakteristik produk Karakteristik produk Lituavi 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Lituavi 01-03-2013
Selebaran informasi Selebaran informasi Hungaria 25-09-2023
Karakteristik produk Karakteristik produk Hungaria 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Hungaria 01-03-2013
Selebaran informasi Selebaran informasi Malta 25-09-2023
Karakteristik produk Karakteristik produk Malta 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Malta 01-03-2013
Selebaran informasi Selebaran informasi Belanda 25-09-2023
Karakteristik produk Karakteristik produk Belanda 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Belanda 01-03-2013
Selebaran informasi Selebaran informasi Polski 25-09-2023
Karakteristik produk Karakteristik produk Polski 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Polski 01-03-2013
Selebaran informasi Selebaran informasi Portugis 25-09-2023
Karakteristik produk Karakteristik produk Portugis 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Portugis 01-03-2013
Selebaran informasi Selebaran informasi Rumania 25-09-2023
Karakteristik produk Karakteristik produk Rumania 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Rumania 01-03-2013
Selebaran informasi Selebaran informasi Slovak 25-09-2023
Karakteristik produk Karakteristik produk Slovak 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Slovak 01-03-2013
Selebaran informasi Selebaran informasi Sloven 25-09-2023
Karakteristik produk Karakteristik produk Sloven 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Sloven 01-03-2013
Selebaran informasi Selebaran informasi Suomi 25-09-2023
Karakteristik produk Karakteristik produk Suomi 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Suomi 01-03-2013
Selebaran informasi Selebaran informasi Swedia 25-09-2023
Karakteristik produk Karakteristik produk Swedia 25-09-2023
Laporan Penilaian publik Laporan Penilaian publik Swedia 01-03-2013
Selebaran informasi Selebaran informasi Norwegia 25-09-2023
Karakteristik produk Karakteristik produk Norwegia 25-09-2023
Selebaran informasi Selebaran informasi Islandia 25-09-2023
Karakteristik produk Karakteristik produk Islandia 25-09-2023
Selebaran informasi Selebaran informasi Kroasia 25-09-2023
Karakteristik produk Karakteristik produk Kroasia 25-09-2023

Peringatan pencarian terkait dengan produk ini

Lihat riwayat dokumen